At GSK, we are committed to improving lives through innovative science and transformative medicines. As the Executive Director, MDT Biomarker Lead, you will play a pivotal role in shaping and implementing clinical biomarker strategies that inform clinical development and decision-making in collaboration with tumor-specific Medicine Development Teams (MDT). This matrix leadership role allows focus on high priority program(s) within the Oncology portfolio and requires extensive experience in the application of clinical biomarkers and translational research within clinical development with the goal to inform right dose, right patient, right drug at the right time. While leading matrix team(s) of Clinical Biomarker experts supporting individual trials, this role will drive the creation and alignment of translational medicine strategies in support of Oncology MDTs.